[go: up one dir, main page]

UA103907C2 - Normal;heading 1;heading 2;heading 3;THERAPEUTIC REGIMEN COMPRISING PEG-INTERFERON, RIBAVIRIN AND VX-950 FOR THE TREATMENT OF HEPATITIS - Google Patents

Normal;heading 1;heading 2;heading 3;THERAPEUTIC REGIMEN COMPRISING PEG-INTERFERON, RIBAVIRIN AND VX-950 FOR THE TREATMENT OF HEPATITIS

Info

Publication number
UA103907C2
UA103907C2 UAA201105121A UAA201105121A UA103907C2 UA 103907 C2 UA103907 C2 UA 103907C2 UA A201105121 A UAA201105121 A UA A201105121A UA A201105121 A UAA201105121 A UA A201105121A UA 103907 C2 UA103907 C2 UA 103907C2
Authority
UA
Ukraine
Prior art keywords
heading
hepatitis
ribavirin
interferon
peg
Prior art date
Application number
UAA201105121A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Роберт С. Кауффман
Сіріл Жан Камій Тіте
Рамон Поло
Хесвейк Рудольф Петер Герхард Ван
Марія Глорія Бемон
Гастон Рафаел Піккіо
Original Assignee
Вертекс Фармасьютікалз Інкорпорейтед
Янссен Фармацевтика Нв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вертекс Фармасьютікалз Інкорпорейтед, Янссен Фармацевтика Нв filed Critical Вертекс Фармасьютікалз Інкорпорейтед
Priority claimed from PCT/US2009/058218 external-priority patent/WO2010036799A1/en
Publication of UA103907C2 publication Critical patent/UA103907C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms.
UAA201105121A 2008-09-24 2009-09-24 Normal;heading 1;heading 2;heading 3;THERAPEUTIC REGIMEN COMPRISING PEG-INTERFERON, RIBAVIRIN AND VX-950 FOR THE TREATMENT OF HEPATITIS UA103907C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9984908P 2008-09-24 2008-09-24
PCT/US2009/058218 WO2010036799A1 (en) 2008-09-24 2009-09-24 Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis "

Publications (1)

Publication Number Publication Date
UA103907C2 true UA103907C2 (en) 2013-12-10

Family

ID=52285354

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201105121A UA103907C2 (en) 2008-09-24 2009-09-24 Normal;heading 1;heading 2;heading 3;THERAPEUTIC REGIMEN COMPRISING PEG-INTERFERON, RIBAVIRIN AND VX-950 FOR THE TREATMENT OF HEPATITIS

Country Status (1)

Country Link
UA (1) UA103907C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2632046C1 (en) * 2014-03-31 2017-10-02 Ниссан Мотор Ко., Лтд. Casting method and casting device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2632046C1 (en) * 2014-03-31 2017-10-02 Ниссан Мотор Ко., Лтд. Casting method and casting device

Similar Documents

Publication Publication Date Title
MX2007005179A (en) Dose forms comprising vx-950 and their dosage regimen.
PH12014500833A1 (en) Methods for treating hcv
MX2009012598A (en) Dose forms comprising vx- 950 and their dosage regimen.
PH12014500832A1 (en) Methods for treating hcv
PL2530083T3 (en) BRUTON tyrosine kinase INHIBITORS
EA033257B1 (en) Combination of two antivirals for treating hepatitis c
PH12014500386A1 (en) Combination treatment for hepatitis c
PH12013500559A1 (en) Combination therapy for treating hcv infection
MX2009006327A (en) Heterocycle compounds and methods of use thereof.
MX2010009624A (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1.
EA201170484A1 (en) THERAPEUTIC MODE OF HEPATITIS TREATMENT, INCLUDING PEG-INTERFERON, RIBAVIRIN AND VX-950
MX2009003532A (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin.
MX2009005798A (en) Stroke recovery.
UA99094C2 (en) Method for the treatment of patients with autoantibody positive disease
EA201071230A1 (en) TREATMENT OF INFECTIONS BY THE HEPATITIS VIRUS WITH TELAPREVIR (VX-950) IN PATIENTS NOT RESPONSIBLE FOR THE TREATMENT BY PEGYLED INTERFERON-ALPHA-2A / 2B AND RIBAVIRIN
DE602006017728D1 (en) CANCER TREATMENT BY AGENT AND 2-DEOXYGLUCOSE
UA103907C2 (en) Normal;heading 1;heading 2;heading 3;THERAPEUTIC REGIMEN COMPRISING PEG-INTERFERON, RIBAVIRIN AND VX-950 FOR THE TREATMENT OF HEPATITIS
EA201491652A1 (en) MEANS FOR TREATING VIRAL HEPATITIS C
WO2008036157A3 (en) Prophylactic and therapeutic treatment of avian influenza infections in animals
TN2013000134A1 (en) Combination therapy for treating hcv infection
TW200500073A (en) Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof
BR112015008681A2 (en) combination